Protandim in the News
From the initial launch on ABC’s PrimeTime Live, to numerous local appearances around the country, learn more about Protandim and see what everyone is talking about.
ABC Primetime
Does a New Pill Contain the Fountain of Youth? Protandim May Slow Aging Process by Increasing Enzymes That Fight Free Radicals.
Watch the Video.
PBS Healing Quest
Healing Quest is a series of half-hour television programs for PBS based on the booming interest in integrative health and natural approaches to well-being.
Watch the Video.
NBC Today Show
Try these 5 secrets to age-proof your body: Live longer and healthier with these nutrition tips from registered dietician Elizabeth Somer.
Watch the Video.
Chemopreventative Effects of Protandim® Examined Further in New Peer-Reviewed Study
Protandim's ability to modulate relationship between superoxide dismutase and tumor suppressor p53 believed responsible for reduction of skin cancers in mice
A study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer. Protandim®, a patented dietary supplement comprised of five highly synergistic herbal ingredients, has been shown in earlier studies to activate the transcription factor Nrf2, a signal to the cell's DNA to regulate a network of protective genes. This new study further investigates Protandim's® ability to increase production of the body's Nrf2-regulated protective genes, sometimes referred to as "survival genes", specifically in regard to chemoprevention.
Click here to view the study.
New Peer Reviewed Study Concludes That Protandim® Improves Markers of Oxidative Stress and Fibrosis in Muscular Dystrophy Mice
The study, titled The Dietary Supplement Protandim® Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice by M.M. Qureshi, W.C. McClure, N.L. Arevalo, R.E. Rabon, B. Mohr, S.K. Bose, J.M. McCord, and B.S. Tseng, documents a 48% decrease in plasma TBARS, a marker of lipid peroxidation and oxidative stress, a 57% decrease in plasma osteopontin, a fibrosis-promoting factor linked to heart failure, and a 35% increase in beneficial, protective plasma PON1 activity in those mice given Protandim® compared to those without Protandim. PON1 is an enzyme thought to protect against atherosclerosis by preventing the oxidation of low-density lipoprotein (LDL) cholesterol.
Click here to view the press release.
Prestigious American Heart Association Journal, Circulation, Publishes New Peer-Reviewed Study Involving Protandim®
Dr. Norbert Voelkel and researchers at Virginia Commonwealth University (VCU), demonstrated the ability of Protandim, the Company's patented dietary supplement composed of five highly synergistic "indirect antioxidants", to protect the heart in a laboratory model of pulmonary hypertension in rats. "We are encouraged by the results of this study, which was independently funded and independently conducted by Dr. Voelkel and his colleagues at VCU," stated David Brown, President & CEO of LifeVantage.
Click here to view the press release.
Peer Reviewed Study from Louisiana State
Peer Reviewed Study from Louisiana State University, "Protandim®, a Fundamentally New Antioxidant Approach in Chemoprevention Using Mouse Two-Stage Skin Carcinogenesis as a Model," Published in PLoS ONE Journal.
Click here to read the study.
AARP Magazine September/October 2009 Issue
Celebrity talk show host and LifeVantage distributor, Montel Williams, appears in this issue of AARP. Montel Williams frequently appears in the media and is excited to talk about his health strategies—he wants his fellow distributors to know that when he references antioxidants in the media he is also referring to Protandim.
To this end, Montel Williams and David Brown, our CEO, have written letters regarding the article.
Delicious Living, antioxidant update
The leading consumer magazine in the natural products industry headlined an article about indirect antioxidants, Dr McCord, and Protandim. Click here to read the article.
Montel Across America
Montel Williams with David Perlmutter, MD, FACN, ABIHM on Montel's radio show Montel Across America, to discuss the science and benefits of Protandim. Click here to listen.
“Dr McCord’s decades of experiments may have the potential of adding years to people’s lives.”
ABC Primetime Video, June 6, 2005
“Oxidative Stress has been linked to as many as 200 diseases so this could be a major breakthrough.”
PBS Healing Quest, May 8, 2006
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.